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Abstract
Background One of the highest rates of illicit cocaine
consumption in Europe is in Spain. Our objective was to
study the incidence and impact of undisclosed cocaine
consumption in patients attending the emergency department
(ED) for trauma or chest pain.
Methods We analysed urine samples from consecutive
patients attending the ED for trauma or chest pain to
determine the presence of cocaine, cannabis, amphetamine/
metaamphetamine and opioids by semiquantative tests with
fluorescence polarization immunoassay (FPIA).
Results Thirty percent of eligible patients participated. Of
75 cases, 61.3% had trauma and 38.7% chest pain; 25%
presented a positive test for drugs. Cocaine was present in
13.3% and cannabis in the same proportion. No differences
were found regarding positive cocaine test and chief
complaint, ED or hospital stay, or additional tests. Cocaine-
positive patients were significantly younger.
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Introduction
The highest illicit cocaine consumption in Europe is in
Spain and the UK [1], on a par with that in the USA [2].
Furthermore, it has increased alarmingly among young
people [3].
Various studies have established a relationship between
acute cocaine consumption and medical attention for chest
pain, especially in people under 45 years of age [4, 5].
Chronic abuse has been postulated as a new factor in
cardiovascular risk [6]. In addition, illicit drug use is
involved to the same extent as alcohol abuse in vehicle
accidents [7] and accidental or violent trauma [8], especial-
ly in severe cases or deaths [9].
To our knowledge, no studies have been performed in
Spain on the prevalence of cocaine consumption in patients
seeking emergency department attention when this was not
the direct reason for the visit [10, 11].
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The objective of this work was to study the incidence of
cocaine consumption in patients attending the emergency
department (ED) for trauma or cardiovascular pathology,
and whether such consumption influenced clinical manage-
ment of the patient.
Patients and methods
Between 1 April and 30 June 2006, we prospectively
studied urine samples from consecutive patients over
16 years who presented to a university hospital ED for
any trauma secondary to vehicle accident, work accident,
aggression, or non-traumatic chest pain of probable
cardiovascular origin. Informed consent was obtained from
these participants except those patients for whom toxico-
logical analysis was performed for clinical reasons. The
samples were stored at –80°C for subsequent analysis.
The following variables were studied: age, sex, reason
for visit (trauma or chest pain), complementary tests needed
(blood tests, X-rays, CT scans and ultrasound), number of
tests performed, outcome (death, hospital admission,
discharge), duration of ED stay for non-admissions and
days of hospital stay.
The detection of drugs in urine samples was performed
by semiquantative tests with fluorescence polarisation
immunoassay (FPIA)(AxSYM System, Abbott laboratories,
Abbott Park, IL), measuring levels of cocaine (benzoylec-
gonine and methylecgonine ether), cannabis (delta-9-tetra-
hydrocannabinol), amphetamine/metaamphetamine, opioids
(morphine and normorphine) and benzodiazepine (nordia-
zepam). We considered the following values as positive:
cocaine >300 ng/ml, cannabis >50 ng/ml, opioids >300 ng/ml,
amphetamine/metaamphetamine >1,000 ng/ml and benzo-
diazepine >200 ng/ml. Polyconsumption was defined as
the presence of two or more drugs in the samples
analyzed.
The project was approved by the local research ethics
committee.
Statistical analysis
Results for categorical variables are expressed as frequency
and percentage. Results for numerical and ordinal variables
are expressed as mean and standard deviation. Proportions
were compared with chi-square test or Fisher’s exact test
whenever required. Ranks between groups were compared
with Mann-Whitney U test or Wilcoxon-Mann-Whitney
test whenever required. A P value of less than 0.05 was
considered to indicate statistical significance.
Statistical analysis was carried out with SPSS v. 14.0.1
(Chicago, IL) and StatXact 5.0 (Cytel Co., Cambridge, MA).
Results
Two hundred and fifty patients fulfilled the inclusion
criteria, but only 91 gave their consent to be included in
the study. Finally, after 16 were excluded due to incomplete
clinical information (patients left ED before the discharge
process was completed), the data from 75 patients were
included for statistical analysis.
Clinical and demographic characteristics are shown in
Table 1. Physical trauma was present in 63.3% of the whole
sample. The chest pain group was older than the trauma
group (36.8 years±17.73 vs. 47.0 years±16.06; P<0.001),
received more blood tests (86.2% vs. 52.2%; P=0.002) and
more electrocardiograms (93.1% vs. 4.3%; P=0.001). No
differences were found in the other variables (see Table 1).
No patients died.
Remarkably, 25.3% (19 of 75) of the patients showed
positive drugs test for drugs. Of these, 13.3% (10 of 75)
were positive for cocaine, and the same percentage was
positive for cannabinoids (Table 2). Patients with positive
Table 1 Clinical and demographic characteristics of patients grouped according to reason for ED visit
Total n=75 Chest pain group n=29 Trauma group n=46 P value
Age (years) 36.8±17.73 47.0±16.06 27.6±9.90 <0.001
Male sex—no. (%) 59 (78.7) 23 (79.3) 36 (78.3) 0.58
Emergency dept. stay (h) 5.2±6.52 6.6±8.50 4.3±4.93 0.99
Hospital admission—no. (%) 19 (25.7) 10 (34.5) 9 (20) 0.13
Hospital stay (days) 4.23±10.43 4.3±6.09 4.19±12.53 0.06
Additional tests—no. (%) 67 (94.4) 26 (96.3) 41 (93.2) 0.51
Blood tests—no. (%) 49 (65.3) 25 (86.2) 24 (52.2) 0.002
X-ray—no. (%) 62 (82.7) 22 (75.9) 40 (87) 0.18
ECG—no. (%) 26 (38.7) 27 (93.1) 2 (4.3) <0.001
CT—no. (%) 11 (14.7) 5 (17.2) 6 (13) 0.43
Echography—no. (%) 5 (6.7) 3 (10.3) 2 (4.2) 0.3
X-ray: radiography, ECG: electrocardiogram, CT: computerized tomography
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test for cocaine were younger than those with negative test
(26.6 years±5.04 vs. 39.7 years±18.96, respectively;
P=0.036). No differences were found between patients with
positive and negative cocaine tests in sex, duration of ED
stay, hospital stay or need for additional tests (Table 3).
However, the proportion of patients with positive test for
more than one illegal drug was higher in the chest pain
group (17.2%) than in the trauma group (0%); P=0.007.
Discussion
A remarkable finding of this study was that one in four ED
patients presenting for reasons other than illicit drug
consumption showed positive drug urine analyses. This
coincides with the findings of Sanjurjo et al. [11], but they
only included undisclosed cases suspected of drug con-
sumption. Moreover, the fact that only 30% of patients
eligible for inclusion in the present study consented to
participate suggests that the number of illicit drug users
attending hospital emergency departments in Spain may be
higher than was previously estimated. A limitation of our
study was precisely this low rate of consent, which
contrasts with that of approximately 70% in other series,
although in those studies the reasons for patients attending
ED were medical problems specifically related with cocaine
consumption [11, 12]. Another limitation may be not having
taken into account the degree of severity or admission
diagnoses to determine their relation with cocaine use. This
was not done because of the small sample size.
Despite studying two groups of patients as aetiologically
different as trauma and chest pain of probable cardiologic
aetiology, we found no significant differences in clinical
characteristics such as ED stay, hospitalisation or hospital
stay. Neither did we find differences in cocaine consump-
tion between the two groups. Both our groups showed
positive cocaine results at the lower limit of other series
(16% [13] to 56.2% [14] for cocaine-related chest pain and
from 6% [15] to 11.8% [12, 16] for trauma patients). A
possible explanation may be that they included mainly
severe cases.
Polyconsumption was higher in the chest-pain group,
probably because the trauma group included any degree of
severity, not just severe trauma as in other series, especially
those associated with alcohol consumption [15, 17].
The use of cocaine was not associated with increased ED
stay, complementary studies, rate of hospital admission or
length of hospital stay. It appears that the use of this
substance had little influence as an independent factor on
expenditure and health resources. This may be partly
attributable to the fact that the cocaine-positive patients
were significantly younger than the cocaine-negative
Table 3 Demographics, ED management and polycompsumption in cocaine-positive patients
Total n=75 Cocaine-positive patients n=10 Cocaine-negative patients n=65 P value
Age (years) 36.8±17.73 26.6±5.04 39.7±18.96 0.04
Male sex—no. (%) 59 (78.7) 10 (16.9) 49 (83.1) 0.08
ED stay (h) 5.2±6.52 5.3±4.5 4.1±6.85 0.39
Hospitalization—no. (%) 19 (25.7) 2 (10.5) 17 (89.5) 0.50
Hospital stay (days) 4.23±10.43 5.0±15.12 4.1±9.57 0.39
Additional tests—no. (%) 67 (94.4) 9 (90) 58 (95.1) 0.46
Blood tests—no. (%) 49 (65.3) 9 (90) 40 (61.5) 0.07
X-ray— no. (%) 62 (82.7) 7 (70) 55 (84.6) 0.24
ECG—no. (%) 26 (38.7) 5 (50) 24 (36.9) 0.32
CT—no. (%) 11 (14.7) 1 (10) 10 (15.4) 0.55
Echography—no. (%) 5 (6.7) 1 (10) 4 (6.2 0.52
Cannabinoids (positive test)—no. (%) 10 (13.3) 4 (40) 6 (60) 0.24
Opioids (positive test)—no. (%) 3 (4) 0 (0) 3 (100) 0.65
X-ray: radiography, ECG:electrocardiogram, CT: computerized tomography
Table 2 Positive drug tests classified according to the reason for ED visit
Total n=75 Chest pain group n=29 Trauma group n=46 P value
Cocaine (+)—no. (%) 10 (13.3) 5 (17.2) 5 (10.96) 0.32
Cannabinoids (+)—no. (%) 10 (13.3) 5 (17.2) 5 (10.96) 0.32
Opioids (+)—no. (%) 3 (4) 2 (6.9) 1 (2.2) 0.33
Amphetamines (+)—no. (%) 0 (0) 0 (0) 0 (0) -
Any illicit drug—no. (%) 19 (25.3) 8 (27.6) 11 (23.9) 0.46
Polyconsumption—no. (%) 5 (6.7) 5 (17.2) 0 (0) 0.007
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patients compared in this study. Precisely for this reason,
we cannot know the future impact of this consumption by
young people [6].
Further research with longer study periods and a greater
number of patients is required to confirm these preliminary
findings.
Conclusions
This study found undisclosed cocaine and cannabis use in
25% of consecutive adult patients presenting at the
emergency department for trauma or chest pain. The low
participation suggests higher real incidence.
The use of cocaine was not associated with greater
health care burden, but cocaine-positive patients were
significantly younger.
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